Related Experiment Videos
[Cervical lymph node metastasis and recurrence in supraglottic carcinoma after operation]
1Department of Otolaryngology, First Affiliated Hospital of China Medical University, Shenyang 110001.
Zhonghua Er Bi Yan Hou Ke Za Zhi
|May 27, 2003
Summary
Elective neck dissection (END) improves survival rates for supraglottic carcinoma patients compared to watchful waiting or salvage surgery. This approach is particularly recommended for advanced T3 and T4 stage cancers.
Area of Science:
- Otolaryngology
- Head and Neck Surgery
- Oncology
Context:
- Supraglottic carcinoma presents a significant challenge in head and neck oncology.
- Management strategies for regional control, particularly concerning the neck, are critical for patient outcomes.
- The role of elective neck dissection (END) versus observation or salvage surgery remains a key area of investigation.
Purpose:
- To retrospectively evaluate the efficacy of elective neck dissection (END) in achieving regional control for patients diagnosed with supraglottic carcinoma.
- To compare survival rates between patients treated with END and those managed with a
- wait and watch
- policy or salvage surgery.
Summary:
- A retrospective review of 582 supraglottic carcinoma patients treated between 1981 and 1993 was conducted.
- Patients with T3/T4 lesions and positive lymph nodes (N+) showed higher recurrence rates without END.
- END in node-negative (N0) patients, especially those with T3/T4 disease, significantly reduced contralateral lymph node recurrence and improved survival rates compared to observation.
Impact:
- Elective neck dissection demonstrates superior regional control and survival benefits for supraglottic carcinoma patients.
- The findings support the recommendation of END as a standard treatment for supraglottic carcinoma, especially in advanced stages (T3 and T4).
- This study contributes to optimizing treatment algorithms for head and neck cancers, potentially improving oncologic outcomes.